In this quiz, we test your knowledge of the AAP's new algorithm and updated recommendations for newborn screening for critical congenital heart disease.
Quiz: Recommendations for critical congenital heart disease newborn screenings | Image Credit: © daqota - © daqota - stock.adobe.com.
In December 2024, the American Academy of Pediatrics (AAP) introduced updates to the critical congenital heart disease (CCHD) screening algorithm to enhance efficiency and accuracy in newborn screenings. These changes include a simplified process that reduces the number of retests and refines the criteria for passing oxygen saturation levels. The goal of these refinements is to decrease misinterpretation, improve sensitivity, and ensure more consistent implementation of CCHD screening across hospitals nationwide.
In this quiz, we test your knowledge of the key changes in the screening algorithm.
Take the quiz below to test your comprehension of the updated screening process and its implications for clinical practice.
Question 1: True or False?
The new CCHD screening algorithm requires both pre- and post-ductal oxygen saturation to be at least 95% for a passing result.
Stay tuned for 2 more quizzes on the AAP's updated CCHD recommendations. The second quiz will be posted to our website on Tuesday, February 25, 2025, and the third will be posted on Tuesday, March 4, 2025.
References:
Oster EM, Nelangi MP, Pramanik AK, et al. Newborn Screening for Critical Congenital Heart Disease: A New Algorithm and Other Updated Recommendations: Clinical Report. Pediatrics January 2025; 155 (1): e2024069667. 10.1542/peds.2024-069667
Fitch, J. Updated pediatric screening recommendations for critical congenital heart disease. Contemporary Pediatrics. January 2, 2025. Accessed February 18, 2025. https://www.contemporarypediatrics.com/view/updated-pediatric-screening-recommendations-for-critical-congenital-heart-disease
Pediatric cancer survivors and cardiovascular toxicity, disease risk
March 21st 2025Pediatric cancer survivors can be vulnerable to cardiovascular disease in the short- or long-term with increased recognition of cardiotoxic cancer treatments, as 5-year survival rates for children are greater than 85%.